Fatty gut needs low-fat formula

Fatty gut needs low-fat formula

Imagine a 5-month-old baby so small they fall below the 5th percentile for weight and height—their body wasted, their days marked by 10 bouts of cheesy, foul-smelling diarrhea. For families facing rare digestive disorders like primary intestinal lymphangiectasia (PIL), hope often lies in a surprising place: what’s not on the plate. A 2019 case study from Dr. Mohammed Hasosah, a pediatric gastroenterologist at King Saud Bin Abdulaziz University for Health Sciences in Jeddah, Saudi Arabia, reveals how a low-fat, medium-chain triglyceride (MCT)-based diet can turn the tide for children with this condition.

PIL is an ultra-rare disease where the tiny lymph vessels (lacteals) lining the small intestine become dilated, leaking lymph fluid into the gut. This triggers “protein-losing enteropathy”—a process where the body loses critical proteins, immune cells, and nutrients. The result? Slow growth, low blood protein (hypoalbuminemia), low immune cells (lymphopenia), and persistent diarrhea. No one knows exactly what causes PIL, and it affects boys and girls equally across all races. Until Dr. Hasosah’s study, cases in Asia were barely documented.

The baby at the heart of the research had struggled since 1 month old: their diarrhea was so severe, their mother described it as “cheesy” and “foul.” Physical exams showed they were “wasted,” with no subcutaneous fat. Blood tests revealed low hemoglobin (102 g/L, vs. the normal 122–153 g/L) and critically low albumin (19 g/L, vs. 35–55 g/L). A stool sample tested positive for alpha-1 antitrypsin—a key marker for protein loss in the gut—while an endoscopy found swollen duodenal lining dotted with white spots. A biopsy confirmed the diagnosis: dilated lymphatics in the small intestine, the signature of PIL.

The solution? A strict low-fat diet and Monogen, a nutritionally complete formula high in MCTs. Unlike long-chain fats (found in most foods), MCTs are absorbed directly into the bloodstream—not through lymph vessels. This means they don’t overload the already swollen lacteals, preventing further leakage and protein loss.

The results were transformative. After 3 months on the diet, the baby gained weight, their diarrhea improved, and blood tests showed normal albumin and stool alpha-1 antitrypsin levels. Crucially, Dr. Hasosah noted the diet must be permanent: if the family stopped the low-fat plan, symptoms returned.

PIL comes in two forms: primary (present at birth or linked to syndromes like Noonan or Hennekam) and secondary (caused by other diseases like lymphoma, Crohn’s, or constrictive pericarditis). While there’s no cure, fat restriction is the “cornerstone” of primary PIL treatment, according to research in Orphanet J Rare Dis. The logic is simple: less fat means less chyle (the milky fluid in lymph) filling lacteals, reducing the risk of rupture and leakage.

For some children, surgery to remove a localized segment of the small intestine may help. Other treatments—like octreotide (a hormone drug), tranexamic acid (an anti-fibrinolytic), or corticosteroids—have been tested, but there’s limited data to confirm their effectiveness, notes a 2015 study in World J Gastroenterol.

Dr. Hasosah’s case is a powerful reminder that personalized nutrition can be life-saving for rare diseases. For families navigating PIL, the takeaway is clear: a low-fat diet with MCT supplementation isn’t just a recommendation—it’s a lifeline. While PIL remains rare, this study shows how understanding the body’s unique needs can help children thrive.

This research was published in Chinese Medical Journal (2019) with ethical approval from King Saud Bin Abdulaziz University for Health Sciences. The patient’s family provided informed consent.

doi.org/10.1097/CM9.0000000000000258
doi.org/10.1186/1750-1172-3-5
doi.org/10.1007/s10620-010-1161-1
doi.org/10.12998/wjcc.v2.i10.528
doi.org/10.1159/000348763
doi.org/10.3748/wjg.v21.i23.7320

Was this helpful?

YesNo

0 / 0